NCT07674914Not yet recruitingPhase 1/2
A Cognitive Mobile Intervention for Motivation in Psychotic Disorders
A User-Informed Digital Therapeutic for Specific Cognitive Disabilities to Improve Mental Health in Schizophrenia and Related Mental Illnesses
Source: ClinicalTrials.gov · Last updated 30 Jun 2026
Brief summary (registry, in English)
The goal of this study is to develop and test the impact of a smartphone-based working memory cognitive training digital therapeutic for individuals with schizophrenia or a related disorder.
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 23 Jun 2026
- Start date
- Sept 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Schizophrenia
- NCT number
- NCT07674914
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 45
- From Sept 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- history of neurological disorder
Other
- traumatic brain injury with loss of consciousness \> 10 minutes or behavioral sequelae.
Who the study is looking for
- diagnosis of schizophrenia, schizoaffective disorder, or a related psychotic disorder
- own a smartphone
- English speaking
- experiencing challenges with cognitive functioning
- no changes to antipsychotic medication in past month
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.